Reversion of transformed phenotype in ovarian cancer cells by intracellular expression of anti folate receptor antibodies
- PMID: 12776159
- DOI: 10.1038/sj.gt.3301962
Reversion of transformed phenotype in ovarian cancer cells by intracellular expression of anti folate receptor antibodies
Abstract
The alpha-folate receptor (FR) is selectively overexpressed in 90% of nonmucinous ovarian carcinomas, whereas no expression is detectable in normal ovarian surface epithelium (OSE). Indirect evidence suggests that FR expression is associated with tumor progression and affects cell proliferation. To evaluate better the role of FR, we developed an approach based on intracellular expression of single-chain (sc) antibodies (intrabody) to downmodulate membrane expression of FR in ovary cancer cells. IGROV-1 and SKOV3 ovarian carcinoma cell lines were transfected with an anti-FR intrabody. Transfectants and parental cells were tested for FR, integrins and anti-FR intrabody expression by fluorescence-activated cell sorting (FACS), reverse transcription and polymerase chain reaction (RT-PCR) and/or immunoblotting. Cell growth characteristics and adhesion properties were evaluated in liquid, semisolid and organotypic cultures. The anti-FR scFv inhibited FR expression from 60 to 99%. At physiological concentrations of folate, proliferation varied directly as a function of FR expression. FR downmodulation was accompanied by reduced colony-forming ability in soft agar, morphological change of the cells, significant enhanced adhesion to laminin or Matrigel, a two- to three-fold increase in alpha6beta4 integrin expression, and a marked reduction in laminin production. In three-dimensional organotypic cultures, anti-FR intrabody-transfected IGROV1 cells grew as a single-ordered layer, reminiscent of normal OSE growth in vivo. In conclusion, the anti-FR intrabody reverses the transformed phenotype in ovary cancer cells and may provide an efficient means to inhibit selectively the growth of these cells.
Similar articles
-
Downmodulation of caveolin-1 expression in human ovarian carcinoma is directly related to alpha-folate receptor overexpression.Oncogene. 2000 Sep 28;19(41):4754-63. doi: 10.1038/sj.onc.1203839. Oncogene. 2000. PMID: 11032026
-
Expression of folate receptor type alpha in relation to cell type, malignancy, and differentiation in ovary, uterus, and cervix.Cancer Epidemiol Biomarkers Prev. 1999 Sep;8(9):775-82. Cancer Epidemiol Biomarkers Prev. 1999. PMID: 10498396
-
Flow cytometric method for determining folate receptor expression on ovarian carcinoma cells.Cytometry A. 2007 Nov;71(11):945-50. doi: 10.1002/cyto.a.20456. Cytometry A. 2007. PMID: 17712798
-
Folate receptors.Annu Rev Nutr. 1996;16:501-21. doi: 10.1146/annurev.nu.16.070196.002441. Annu Rev Nutr. 1996. PMID: 8839936 Review.
-
Role of the folate receptor in ovarian cancer treatment: evidence, mechanism, and clinical implications.Cancer Metastasis Rev. 2015 Mar;34(1):41-52. doi: 10.1007/s10555-014-9539-8. Cancer Metastasis Rev. 2015. PMID: 25564455 Review.
Cited by
-
Relationship between dietary and supplemental intake of folate, methionine, vitamin B6 and folate receptor alpha expression in ovarian tumors.Int J Cancer. 2010 May 1;126(9):2191-8. doi: 10.1002/ijc.24723. Int J Cancer. 2010. PMID: 19585555 Free PMC article.
-
Therapeutic strategies targeting folate receptor α for ovarian cancer.Front Immunol. 2023 Aug 30;14:1254532. doi: 10.3389/fimmu.2023.1254532. eCollection 2023. Front Immunol. 2023. PMID: 37711615 Free PMC article. Review.
-
Intracellular Acidosis Promotes Mitochondrial Apoptosis Pathway: Role of EMMPRIN Down-regulation via Specific Single-chain Fv Intrabody.J Cancer. 2015 Jan 20;6(3):276-86. doi: 10.7150/jca.10879. eCollection 2015. J Cancer. 2015. PMID: 25663946 Free PMC article.
-
Role of antibody engineering in generation of derivatives starting from MOv19 MAb: 40 years of biological/therapeutic tools against folate receptor alfa.Antib Ther. 2022 Oct 27;5(4):301-310. doi: 10.1093/abt/tbac026. eCollection 2022 Oct. Antib Ther. 2022. PMID: 36518225 Free PMC article. Review.
-
Emerging roles for folate receptor FOLR1 in signaling and cancer.Trends Endocrinol Metab. 2022 Mar;33(3):159-174. doi: 10.1016/j.tem.2021.12.003. Epub 2022 Jan 31. Trends Endocrinol Metab. 2022. PMID: 35094917 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical